Anticoagulation as secondary prevention of massive lung thromboses in hospitalized patients with COVID-19

Eur J Intern Med. 2022 Jun:100:21-24. doi: 10.1016/j.ejim.2022.04.009. Epub 2022 Apr 13.

¹ Department of Anesthesia and Intensive Care, IRCCS San Raffaele Scientific Institute, Milan, Italy.
² Department of Anesthesia and Intensive Care, IRCCS San Raffaele Scientific Institute, Milan, Italy; Unit of Immunology, Rheumatology, Allergy and Rare Diseases, IRCCS San Raffaele Scientific Institute, Milan, Italy. Electronic address: landoni.giovanni@hsr.it.
³ Department of Anesthesia and Intensive Care, IRCCS San Raffaele Scientific Institute, Milan, Italy; Unit of Immunology, Rheumatology, Allergy and Rare Diseases, IRCCS San Raffaele Scientific Institute, Milan, Italy.
⁴ Unit of Immunology, Rheumatology, Allergy and Rare Diseases, IRCCS San Raffaele Scientific Institute, Milan, Italy; Faculty of Medicine, Vita-Salute San Raffaele University, Milan, Italy. Electronic address: dagna.lorenzo@unisr.it.

No abstract available

Keywords: Anticoagulants; Antithrombotic therapy; COVID-19; MicroCLOTS; SARS-CoV-2; Thromboinflammatory syndrome.

MeSH terms